insights_auto
Why is INO down २१.०३%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.१४
arrow_downward
-२१.०३%(-०.३१) 1D
नोभेम्बर ६, १२:५३:२७ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.१२
High
US$ १.१९
Low
US$ १.०७
Mkt. cap
११.९४ करोड
Avg. vol.
१.६२ करोड
Volume
२.७६ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.१२
High
US$ १.१९
Low
US$ १.०७
Mkt. cap
११.९४ करोड
Avg. vol.
१.६२ करोड
Volume
२.७६ करोड
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ १.१७
Beta
१.७१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Investing.com
·
६ मिनेट पहिले
Why is Inovio Pharmaceuticals stock plunging today?
BigGo Finance
·
३० मिनेट पहिले
Inovio Shares Sink 25% After $75 Million Stock Sale Priced at $1.05
Investing.com
·
१ घण्टा पहिले
Inovio stock tumbles 25% on $75M share offering
Yahoo Finance
·
३ घण्टा पहिले
The end of MAHA?; Inovio’s big FDA win
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc